Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1517705rdf:typepubmed:Citationlld:pubmed
pubmed-article:1517705lifeskim:mentionsumls-concept:C0042153lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C0242694lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C0021665lld:lifeskim
pubmed-article:1517705lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:1517705pubmed:issue1lld:pubmed
pubmed-article:1517705pubmed:dateCreated1992-10-8lld:pubmed
pubmed-article:1517705pubmed:abstractTextThis study investigated the effects of insulin-like growth factor-I (IGF-I) administered to rats in vivo on the soleus muscle isolated from these rats. In order to study the interactions between IGF-I and insulin, the soleus muscles were incubated in the presence of various concentrations of insulin. IGF-I (190-200 micrograms) was given twice daily; the rats were killed 1 h after one injection of IGF-I (acute administration) or after treatment with IGF-I for 10 days (prolonged administration). The level of IGF-I in plasma was increased by approximately 100% after acute administration and by around 30% after 10 days of treatment with IGF-I. Acute administration of IGF-I to the rats increased the flux of glucose to hexose monophosphate and the rates of lactate formation and glycogen synthesis in the soleus muscles; however, the responsiveness of these muscles to insulin was lost: the increase in the rate of glucose utilization by IGF-I at physiological concentrations of insulin (10 or 100 mU/l) was similar to that observed at maximal concentrations of insulin (1000 mU/l). Similar results were obtained after prolonged treatment of the rats with IGF-I; however, the increase in the rate of glucose utilization was less pronounced than when IGF-I was given acutely and the muscles were still capable of responding to insulin.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1517705pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1517705pubmed:languageenglld:pubmed
pubmed-article:1517705pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1517705pubmed:citationSubsetIMlld:pubmed
pubmed-article:1517705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1517705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1517705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1517705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1517705pubmed:statusMEDLINElld:pubmed
pubmed-article:1517705pubmed:monthAprlld:pubmed
pubmed-article:1517705pubmed:issn0022-0795lld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:NewsholmeE...lld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:BevanSSlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:KrauseUUlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:TaylorAAlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:DimitriadisGGlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:WegenerGGlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:Parry-Billing...lld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:DungerDDlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:ColquhounAAlld:pubmed
pubmed-article:1517705pubmed:authorpubmed-author:CalderPPlld:pubmed
pubmed-article:1517705pubmed:issnTypePrintlld:pubmed
pubmed-article:1517705pubmed:volume133lld:pubmed
pubmed-article:1517705pubmed:ownerNLMlld:pubmed
pubmed-article:1517705pubmed:authorsCompleteYlld:pubmed
pubmed-article:1517705pubmed:pagination37-43lld:pubmed
pubmed-article:1517705pubmed:dateRevised2010-8-25lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:meshHeadingpubmed-meshheading:1517705-...lld:pubmed
pubmed-article:1517705pubmed:year1992lld:pubmed
pubmed-article:1517705pubmed:articleTitleEffects of in-vivo administration of insulin-like growth factor-I on the rate of glucose utilization in the soleus muscle of the rat.lld:pubmed
pubmed-article:1517705pubmed:affiliationDepartment of Biochemistry, University of Oxford, U.K.lld:pubmed
pubmed-article:1517705pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1517705pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:1517705pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1517705lld:pubmed